Vanguard Amends 13G, Reports 0 Shares of Evolus
The Vanguard Group amended its Schedule 13G to report that it beneficially owns 0 shares (0%) of Evolus Inc. common stock following an internal realignment.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
The Vanguard Group amended its Schedule 13G to report that it beneficially owns 0 shares (0%) of Evolus Inc. common stock following an internal realignment. The filing cites the SEC Release No. 34-39538 disaggregation guidance and states certain Vanguard subsidiaries will report separately after the realignment.
The amendment clarifies voting and dispositive powers as 0 and notes the change in reporting structure that led to separate beneficial‑ownership filings by former Vanguard divisions.
Insights
Amendment confirms disaggregated reporting and zero beneficial ownership.
The filing records 0 shares and 0% ownership and cites an internal realignment effective January 12, 2026 under SEC Release No. 34-39538. This is an administrative change where related Vanguard entities will report separately.
Impact is procedural: cash‑flow treatment and trading intent are not disclosed. Subsequent filings from Vanguard subsidiaries may show holdings if applicable.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does The Vanguard Group's Schedule 13G/A say about EOLS ownership?
Why did Vanguard report zero ownership of Evolus (EOLS)?
Who signed the amendment reporting Vanguard's position in EOLS?
Will other Vanguard entities report Evolus holdings after this amendment?
AI-generated analysis. How Rhea-AI works. Not financial advice.